Eckert & Ziegler SE (XTER:EUZ) Research & Development : €0.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Eckert & Ziegler SE Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Eckert & Ziegler SE's Research & Development for the three months ended in Mar. 2024 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was €0.0 Mil.

Eckert & Ziegler SE Research & Development Historical Data

The historical data trend for Eckert & Ziegler SE's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eckert & Ziegler SE Research & Development Chart

Eckert & Ziegler SE Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Research & Development

Get a 7-Day Free Trial

3.75

3.78

3.17

4.33

Eckert & Ziegler SE Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Research & Development	Get a 7-Day Free Trial															-	-	-	-	-

Eckert & Ziegler SE Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

Eckert & Ziegler SE (XTER:EUZ) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Eckert & Ziegler SE Research & Development Related Terms

Thank you for viewing the detailed overview of Eckert & Ziegler SE's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Eckert & Ziegler SE (XTER:EUZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Eckert & Ziegler SE (XTER:EUZ) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

1EUZ:Italy 0NZY:UK

Address

Robert-Rossle-Street 10, Berlin, BB, DEU, D-13125

Website

https://www.ezag.com

Eckert & Ziegler Strahlen- und Medizintechnik AG is a provider of isotope technology for medical, scientific and industrial use. It is primarily engaged in the business activities of cancer therapy, industrial radiometry, and nuclear-medical imaging. The business segments of the group are Isotope products; Medical and Holding company. The company generates maximum revenue from Isotope products segment. Geographically, it derives a majority of revenue from Europe and also has a presence in North America, Asia-Pacific, and other regions.

Executives

Dr. Andreas Eckert	Supervisory Board
Frank Perschmann	Supervisory Board
Dr. Hakim Bouterfa	Board of Directors
Prof. Dr. Wolfgang Maennig	Supervisory Board
Dr. Harald Hasselmann	Board of Directors

Eckert & Ziegler SE (XTER:EUZ) Headlines

No Headlines